Sharapova’s doping ban reduced to 15 months

Sharapova’s doping ban reduced to 15 months
October 05 07:21 2016

Five-time Grand Slam champion Maria Sharapova has had her two-year doping ban reduced to 15 months.

The 29-year-old, who has suffered from persistent shoulder injuries, admitted in March she had tested positive for meldonium at January’s Australian Open.

A two-year ban was imposed by the International Tennis Federation in June, back-dated to January, and she appealed to the Court of Arbitration for Sport (CAS) seeking a reduction.

A 24 month would have meant her missing two years out of the sport, which would almost inevitably had led to her retirement.

But now she can return on April 25, which puts her in position to make her comeback at the French Open at Roland Garros in May.

The Switzerland-based arbitration panel said they had ‘found that Ms Sharapova committed an anti-doping rule violation and that while it was with ‘no significant fault’, she bore some degree of fault, for which a sanction of 15 months is appropriate’.

Sharapova said today: ‘I’ve gone from one of the toughest days of my career last March when I learned about my suspension to now, one of my happiest days, as I found out I can return to tennis in April.

‘In so many ways, I feel like something I love was taken away from me and it will feel really good to have it back. Tennis is my passion and I have missed it. I am counting the days until I can return to the court.’

Maria Sharapova tested positive for meldonium earlier this year

Steve Simon, CEO of the WTA tour, also welcomed the ruling: ‘We are pleased that the process is now at completion and can look forward to seeing Maria back on court in 2017.’

Sharapova was born in Russia but moved to the US in 1994, now lives in Florida and is a US citizen.

Shamil Tarpishev, president of the Russian tennis federation, said: ‘It’s good, they reduced the ban. We want her to play for the national team and win the next Olympics for us.’

Maria Sharapova (pictured) has earned £223 million during her career

Sharapova, who won a silver medal at London 2012, was forced to sit out the Rio 2016 Olympics after the appeal was postponed.

Sharapova argued she had been using a Latvian-made heart disease drug under medical advice for a decade and had not realised it had been added to the World Anti-Doping Agency’s banned list on January 1, 2016.

But an ITF disciplinary panel dismissed this explanation, pointing out meldonium had been on WADA’s ‘watch list’ of controversial drugs for over a year and there had been numerous warnings to athletes about it becoming prohibited in late 2015.

Daily Mail UK